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Abstract 41 
By recruiting functional domains supporting DNA condensation, cell binding, 42 
internalization, endosomal escape and nuclear transport, modular single-chain 43 
polypeptides can be tailored to associate with cargo DNA for cell-targeted gene 44 
therapy. Recently, an emerging architectonic principle at the nanoscale has permitted 45 
tagging protein monomers for self-organization as protein-only nanoparticles. We have 46 
studied here the accommodation of plasmid DNA into protein nanoparticles assembled 47 
with the synergistic assistance of end terminal poly-arginines (R9) and poly-histidines 48 
(H6). Data indicate a virus-like organization of the complexes, in which a DNA core is 49 
surrounded by a solvent-exposed protein layer. This finding validates end-terminal 50 
cationic peptides as pleiotropic tags in protein building blocks for the mimicry of viral 51 
architecture in artificial viruses, representing a promising alternative to the conventional 52 
use of viruses and virus-like particles for nanomedicine and gene therapy. 53 
54 
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Background 55 
Non-viral gene therapy and in general emerging nanomedicines aim to mimic viral 56 
activities in tuneable nanoparticles, for the cell-targeted delivery of cargo nucleic acids 57 
and other drugs [1;2]. Among a diversity of tested materials (including lipids, natural 58 
polymers, quantum dots, carbon nanotubes and dendrimers), proteins offer full 59 
biocompatibility, biodegradability, and a wide spectrum of functionalities that can be 60 
further adjusted by genetic engineering. Such a functional versatility is in contrast with 61 
the null control so far exercised over the supramolecular organization of de novo 62 
designed building blocks for protein-based complexes  [3]. While protein nanoparticles 63 
based on natural cages, mainly infectious viruses [4], virus-like particles (VLPs) [5], 64 
eukaryotic vaults [6] and bacterial microcompartments (BMCs) [7] take advantage of 65 
the evolutionarily optimized self-assembling activities of their building blocks, fully the 66 
novo multifunctional protein monomers fail to reach predefined nanoscale organization. 67 
Only a very limited number of approaches, based on the engineering of oligomerization 68 
domains present in nature have resulted in the successful construction of efficient 69 
building blocks for protein shell generation [8]. Complexes of DNA and cationic proteins 70 
often result in polydisperse soluble aggregates probably derived from intrinsically 71 
disordered protein-protein interactions [9;10], or in which the DNA itself plays a leading 72 
architectonic role, stabilizing aggregation-prone protein monomers in form of 73 
monodisperse nanoparticles [11]. Self-assembling peptides, that organize as different 74 
types of nanostructured materials [12], promote unspecific aggregation when fused to 75 
larger proteins [13;14], making them useless as fine architectonic tags. In summary, 76 
the rational de novo design of protein monomers with self-assembling activities has 77 
remained so far unreachable. Very recently [15], we have described that pairs of 78 
‘architectonic’ peptides consisting of an N-terminal cationic stretch plus a C-terminal 79 
polyhistidine, when combined in structurally diverse scaffold proteins (GFP, p53 and 80 
others), generate strongly dipolar charged monomers that spontaneously self-81 
assemble. The resulting protein oligomers, ranging from 10 to 50 nm, show fast nuclear 82 
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migration (compatible with cytoskeleton-linked active transport) and penetrability [16], 83 
high stability and proper biodistribution upon systemic administration [17]. Important 84 
levels of gene expression where also achieved when the protein was associated to 85 
plasmid DNA [18]. Yet these protein particles efficiently bind plasmid DNA for 86 
transgene expression and are very promising tools in nanomedicine [18], their 87 
supramolecular organization remains so far unexplored. The purpose of this study is to 88 
investigate the architectonic properties of the polyplexes formed by expressible DNA 89 
and the paradigm protein R9-GFP-H6, to better understand the basis of the high cell 90 
penetrability and at which extent the resulting complexes adopt virus-like organization. 91 
A solid comprehension of how multifunctional proteins interact with exogenous DNA 92 
should enable the design and efficient biofabrication of true artificial viruses. 93 
 94 
Methods 95 
Protein production and DNA binding 96 
The modular organization of R9-GFP-H6 [18], T22-GFP-H6 [17] and HNRK [11] has 97 
been described elsewhere. GFP-H6 is a parental version of R9-GFP-H6 and T22-98 
GFP-H6 that does not self-assemble under physiological conditions [15;18]. Apart 99 
from their architectonic capability, R9 (RRRRRRRRR) acts as a cell penetrating 100 
peptide and nuclear localization signal [18] and T22 (RRWCYRKCYKGYCYRKCR) as 101 
a powerful ligand of the cell surface receptor CXCR4 [17]. Both stretches, being 102 
cationic, are potentially able to bind DNA. H6 (HHHHHH) is at the same time a useful 103 
tag for one-step chromatographic protein purification and a potent endosomolytic 104 
agent [19]. Precise amino acid sequences at the links between GFP and the fused 105 
peptides can be found elsewhere [17]. The protein constructs indicated above were 106 
produced in bacteria following conventional procedures and purified in a single step by 107 
His-based affinity chromatography [15], through activities assisted by the Protein 108 
Production Platform (CIBER-BBN) (http://www.bbn.ciber-109 
bbn.es/programas/plataformas/equipamiento). Protein-DNA complexes were 110 
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generated by incubation at appropriate ratios in HBS buffer (pH 5.8) for 60 min at 111 
room temperature.  112 
 113 
Cell culture, confocal microscopy and transmission electron microscopy (TEM) 114 
HeLa (ATCC-CCL-2) cell line was cultured as previously described [16] and always 115 
monitored in absence of fixation to prevent internalization artefacts. Nuclei were 116 
labelled with 200 ng/ml Hoechst 33342 (Molecular Probes, Eugene, Oregon, USA) 117 
and plasma membranes with 2.5 µg/ml CellMaskTM Deep Red (Molecular Probes, 118 
Invitrogen, Carlsbad, CA, USA) for 5 min. Cells exposed to nanoparticles were 119 
recorded with a TCS-SP5 confocal laser scanning microscope (Leica Microsystems, 120 
Heidelberg, Germany) with a Plan Apo 63x / 1.4 (oil HC x PL APO lambda blue) 121 
objective. Three-dimensional cell models were generated with the Imaris v. 6.1.0 122 
software (Bitplane; Zürich, Switzerland). For TEM, protein/DNA complexes were 123 
contrasted by evaporation of 1 nm platinum layer in carbon-coated grids and then 124 
visualized in a Hitachi H-7000 transmission electron microscope.  125 
 126 
DNA protection assay 127 
In the buffers optimal for their respective stability [11;15], R9-GFP-H6 and GFP-H6 128 
(HBS pH 5.8), T22-GFP-H6 (carbonate buffer, pH 5.8) and HNRK (HBS + dextrosa pH 129 
5.8) were mixed with 1 µg of plasmid DNA (pTurboFP635, [18]) at 1 and 2 retardation 130 
units. Mixtures were incubated at room temperature for 1 h and then threated with 0.5 131 
µg/ml DNAse I (Roche) at 37º C, in presence of 2.5 mM MgCl2 and 0.5 mM CaCl2. 132 
Samples were collected just before DNAse I addition and at 5, 20 and 60 min of the 133 
digestion reaction. DNAse I was inactivated by adding EDTA 2.3 µM final 134 
concentration and by heating the samples for 20 min at 70º C. The remaining DNA 135 
was released from protein complexes by adding 10 U of Heparin followed by 2 hours 136 
incubation at 25º C. Subsequently, samples were analyzed in 1% agarose gels. DNA 137 
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signals in agarose gel were interpreted and analyzed with Quatity One software (Bio-138 
Rad). Experiments were performed by triplicate. 139 
 140 
Determination of particle size and Z potential  141 
Volume size distributions of self-assembled protein nanoparticles and protein-DNA 142 
complexes were determined by triplicate using a dynamic light scattering (DLS) 143 
analyser at the wavelength of 633 nm, combined with non-invasive backscatter 144 
technology (NIBS) (Zetasizer Nano ZS, Malvern Instruments Limited, Malvern, U.K.). Z 145 
Potencial of these materials was determined in the same device in HBS buffer (pH 5.8, 146 
10 μg/mL final protein concentration). Measurements were carried out at 25 °C using a 147 
disposable plastic cuvette. Each sample was analysed by triplicate. 148 
 149 
Molecular modelling 150 
To build R9-GFP-H6-based particles, a model of the monomer was first generated 151 
using Modeller 9v2 [20] and the pdb structure "1qyo" as template. The arginine and 152 
histidine tails were modeled using the loopmodel function of this package. The 153 
structural models of the assembled monomers at pH 7 and pH 5.8 were then created 154 
using HADDOCK 2.0 [21], with the protonation states chosen according to pH and 155 
residue pKas, defining the 9 arginines at the N-terminus as active residues and the 6 156 
histidines at the C-terminus as passive residues and enforcing C5 symmetry led to 157 
star-shaped conformations. Alternative conformations were obtained using the tail 158 
arginines as active residues and no passive ones. All these models where analysed 159 
with FoldX using the function "AnalyseComplex" [22]. Defaults were taken for any 160 
other simulation parameters. This protocol has been already used in a previous study 161 
[18]. DNA was modeled for a 26 bp random sequence with the 3DDART server [23] 162 
using default parameters. The structural model of the (1:1) DNA-protein complex was 163 
created with HADDOCK2.0 using N-terminal-tail arginines and C-terminal-tail 164 
histidines as active residues and all DNA bases as passive ones. Superposition of all 165 
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resulting solutions was performed with PROFIT [24] (an implementation of the 166 
McLachlan algorithm, [25]) , using only the DNA molecule as subject of the structural 167 
fit. The structural comparison of disks made of TMV coat protein and R9-GFP-H6 was 168 
performed with SwissPdbViewer* [26] to superimpose the 2om3 PDB structure and 169 
the modelled building block [27]. To facilitate the visualization of the resulting models, 170 
images were generated using Chimera [28] as rendering tool. 171 
 172 
Results  173 
Hexahistidine tails, when combined in single chain polypeptides with N-terminal 174 
cationic peptides, such as R9 or T22, promote assembling of these building blocks as 175 
regular particles at neutral or slightly acidic pH values [15], at which the imidazol group 176 
gets protonated and the tag moderately cationic [19]. When nanoparticles formed by 177 
R9-GFP-H6 at pH 7 and 8 (Figure 1a) were incubated with DNA, particle size remained 178 
close to 20 nm (Figure 1 b), the size previously observed in absence of DNA [15]. At 179 
pH 4 and 10, protein-DNA complexes peaked at 0.8 and 2 µm respectively (Figure 1 b), 180 
which is in agreement with the tendency of the protein alone to form amorphous 181 
aggregates under denaturing conditions Figure 1 a). Interestingly, at slightly acidic pH 182 
(5.8), where the transfection mediated by R9-GFP-H6 had resulted more efficient [15], 183 
the population of polyplexes split in two fractions, peaking at 38 and 700-800 nm 184 
respectively, with no symptoms of protein instability or aggregation (protein-only 185 
nanoparticles peaked between 20 and 30 nm). The ability of these protein constructs to 186 
bind DNA was generically confirmed by retardation mobility assays (Figure 1 c). 187 
 188 
These polyplexes were examined by confocal microscopy during exposure to cultured 189 
cells, taking advantage of the natural green fluorescence of the protein partner and 190 
upon staining the DNA with the blue fluorescent dye Hoechst 33342. Small spherical 191 
particles (Figure 2 a) and larger rod-shaped versions, some slightly twisted or ramified 192 
(Figure 2 b) were observed, whose size fitted respectively to the two main peaks 193 
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determined by DLS (Figure 2 b). The blue DNA signal appeared coincident with the 194 
green label, but its slightly smaller size suggested that DNA occurred in inner cavities 195 
of protein entities. Qualitatively, rod-shaped nanoparticles seemed more efficient in 196 
embedding DNA than the regular versions, as an important fraction of spheres, but not 197 
rods, appeared to be empty (Figure 2 a, b). Fine confocal sections and 3D isosurface 198 
reconstructions strongly suggested that a core DNA was shielded by a solvent-exposed 199 
protein layer (Figure 2 c), in a virus-like architectonic scheme. 200 
 201 
In this regard, rod-shaped forms shown in Figure 2 a and c strongly evoked the 202 
morphologies of capsid proteins observed in plant viruses. Furthermore, a 203 
superimposition of the RNA-containing, rod-shaped tobacco mosaic virus (TMV) disk (a 204 
structural intermediate in the construction of helical capsids) and an energetically 205 
stable, planar, star-shaped molecular model of the self-assembled R9-GFP-H6 at pH 206 
5.8 are presented (Figure 2 d), showing coincidence in diameter and in monomer 207 
organization. Interestingly, a similar spatial distribution of arginines around the central 208 
cavities was found in both viral and non-viral complexes (Figure 2 d, inset). TEM 209 
images of material deposited on the gird in absence of cells indicated again a 210 
prevalence of tubular structures (Figure 2 e), with a diameter compatible with the 211 
particles observed by confocal analyses (between 20 and 30 nm) and with R9-GFP-H6 212 
disks obtained by molecular modelling (Figure 2 d). Importantly, no DNA was found 213 
associated to internalized R9-GFP-H6 protein-only nanoparticles (Figure 2 f). This 214 
indicates that cellular nucleic acids that the protein complexes might eventually find 215 
during the intracellular trafficking would result not available for binding, and that the 216 
only cargo suitable to form artificial viruses is the nucleic acid loaded in vitro. 217 
 218 
Furthermore, DNA embedded in R9-GFP-H6 shells resulted highly protected from 219 
DNAse I attack (Figure 3 a). This effect was similar to that promoted by the closely 220 
related, self-assembling construct T22-GFP-H6. Contrarily, the short modular peptide 221 
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HNRK [18;29], that although being positively charged does not exhibit architectonic 222 
properties, failed in protecting DNA from digestion (Figure 3 a). In the HNRK-DNA 223 
polyplexes, from which DNA overhangs, the nucleic acid is the main architectonic 224 
regulator of the resulting particles (of around 80 nm), the protein fraction being 225 
clustered by DNA instead of entrapping it in shell-like structures [11]. The high 226 
protection of R9-GFP-H6-linked DNA also indicates that whether DNA molecules are 227 
externally associated to some protein particles as suggested by confocal analysis 228 
(Figure 2), the fraction of such material is statistically low. 229 
 230 
Why at slightly acidic pH and in presence of DNA, R9-GFP-H6 ~20 nm-nanoparticles 231 
rearrange as alternative spherical or cylindrical shells remains to be solved, but it might 232 
be speculated that the dipolar nature of the modular protein would permit a 233 
reorganization of the building blocks, to orient the positive protein patches at the inner 234 
surface of the shell, in contact with DNA. For that, spheres and cylinders would permit 235 
appropriate protein-protein interactions. In agreement with this hypothesis, the 236 
superficial charge of protein-only particles was -16.2±1.8 mV, while in presence of 237 
plasmid DNA (2 RU) it shifted to a more negative value (-24.5±2.0 mV) (Figure 3 b). 238 
Interestingly, by applying the same amount of protein, the number of nanoparticles was 239 
reduced by more than 50 % in the presence of DNA, consistent with a higher protein 240 
demand to form nanoparticles up to 800 nm than to form protein-only nanoparticles of 241 
~20 nm. On the other hand, the organization of protein shells as spheres or 242 
alternatively as rods would require a certain degree of flexibility in monomer-monomer 243 
contacts, allowing alternative arrangements of the oligomers. The in-equilibrium 244 
protonation and charge profile of the histidine tail population (pK~6) [19], would confer 245 
enough structural versatility of these interactions supportive of spherical and disk-246 
based cylindrical organization. In agreement, alternative stable versions of R9-GFP-H6 247 
oligomers (pentamers) resulted from the docking process, sustained by slightly 248 
divergent styles of inter-molecular interactions (Figure 4 a). Such pentamers, similarly 249 
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distributed oligomers (eg hexamers) orf their combination, could support both spherical 250 
and rod-shaped architectures as in the case of virus shells. After careful analysis of 251 
these models, we have identified, apart from electrostatic interactions (-7.33 Kcal/mol), 252 
van der Wals forces as the main components keeping the monomers together (-42.38 253 
Kcal/mol), in some cases with hydrogen bonds (-29.13 Kcal/mol) 254 
contributing significantly to the stability of the oligomers (data taken from the model 255 
disk represented in Figure 1 d and in Figure 4 a, left).  256 
 257 
Figure 4 b shows a potential mode of interaction between DNA and R9-GFP-H6, based 258 
on unspecific charge-charge interactions between DNA and the GFP-overhanging tails. 259 
This architecture would enable the organization of several GFP molecules around a 260 
single DNA helix in a form similar to those shown in Figure 2 d for RNA, as suggested 261 
by the superposition of the best 50 solutions of a (1:1) DNA-protein docking simulation, 262 
which shows a uniform distribution of GFP-based building blocks around the DNA.  263 
 264 
Discussion 265 
The severe biological risks and negative media perception associated to the 266 
administration of natural viruses [30] have dramatically compromised the development 267 
of viral gene therapy [31;32] and prompted researchers to explore manmade 268 
alternatives as vehicles for the delivery of therapeutic genes. The artificial virus concept 269 
[2] claims the use of nanoparticles, that upon convenient upstream design, biological 270 
fabrication and engineering can successfully mimic properties of the viral infectious 271 
cycle that are relevant to transgene delivery and expression [33]. Nanotechnologies 272 
and material sciences offer interesting approaches to generate functional 273 
nanostructured carriers, and a spectrum of materials are being explored in this regard 274 
[34], even under suspicion of potential toxicity [35]. Among them, proteins are the most 275 
versatile regarding structure and function, being fully biocompatible, suitable of 276 
biological fabrication and not posing safety of toxicity concerns. In fact, vaults and 277 
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BMCs, or the recombinant version of viruses, namely VLPs, can be conveniently 278 
adapted to embed cargo molecules for targeted delivery [36]. In a more versatile 279 
approach, modular proteins containing cationic stretches for nucleic acid binding and 280 
condensation, as well as other functional segments such as cell penetrating peptides, 281 
ligands or nuclear localization signals, have been under continuous design to recruit 282 
virus-like functions in single chain molecules [37-40]. However, despite the functional 283 
versatility of these constructs they fail to reach ordered nanoscale structures, in most 284 
cases being the DNA the main driving force of the polyplexe architecture [11]. In fact, 285 
the assembly of viral capsids results from a complex combination of intermolecular 286 
interactions including hydrophobic, electrostatic, van der Waals, and hydrogen bonds 287 
[41] that are excluded from a rational design in the novo designed recombinant 288 
proteins. Recently, we have determined that a combination of a cationic peptide plus a 289 
hexahistidine, placed at the amino and caboxy termini respectively of modular proteins 290 
grant them with the ability to self-organize as regular protein-only nanoparticles, able to 291 
penetrate target cells and to reach the nucleus in a very efficient way [15-17]. We have 292 
here shown how at a slightly acidic pH and in presence of DNA, the contacts promoted 293 
by the hexahistidine tail are able to accommodate structural rearrangements, among 294 
others those promoting a re-orientation of cationic segments in the inner surface, that 295 
convert plain oligomers into more complex supramolecular structures, namely closed 296 
protein shells, in a virus-like fashion (Figures 1, 2). Both conventional isometric and 297 
rod-shaped architectonic models occurring in natural viruses are spontaneously 298 
reached by the self-assembling of tagged GFP-H6, efficiently embedding the foreign 299 
DNA in the inner cavity of a protein-only shell (Figure 2). Such a dual construction 300 
scheme at the nanoscale reminds the organization of viral proteins. The rotavirus VP6 301 
capsid protein, whose essential organization is a trimer, assembles into either 302 
nanotubes or nanospheres when produced as a recombinant version [42]. Cationic 303 
peptides R9 and H6 promotes the oligomerization of a monomeric GFP into particles 304 
whose size measured by DLS (Figure 1 a) is compatible with that of pentamers (or 305 
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eventually hexamers, Figure 4 a). The presence of exogenous DNA upon in vitro 306 
incubation stimulates the arrangement of these building blocks in higher order, larger 307 
complexes (Figure 1 b) with flexibility to form nanospheres and nanotubes (Figure 2). 308 
The organizing ability of DNA over cationic proteins to rend ordered protein-DNA 309 
complexes has been reported previously ([11] and references therein), and cationic 310 
interactions seem to be the driving force for the primary DNA-protein interaction (Figure 311 
1 c), that result in nuclease attack protection (Figure 3). The ability of R9-GFP-H6 312 
oligomers to bind and combine with nucleic acids is restricted to exogenous DNA, as 313 
not protein-DNA complexes were observed when mammalian cells were exposed to 314 
protein alone, which efficiently internalizes cultured cells ([16] and Figure 2 f). In 315 
addition, the carrier DNA promotes important levels of gene expression, the whole R9-316 
GFP-H6-DNA complexes acting structurally and functionally like artificial viruses. 317 
 318 
Importantly, the ability of the end-terminal tags of cationic nature to promote protein 319 
self-assembling seems to be irrespective of the polypeptide chosen as the core of the 320 
assembly, or at least not limited to a particular protein species [15]. This opens a door 321 
to select non-immunogenic homologous protein candidates as building blocks of 322 
nanoparticles in order to avoid any immune response upon systemic administration, 323 
what could be a critical bottleneck to the therapeutic use of artificial viruses based on 324 
de novo designed self-assembling proteins. 325 
 326 
In summary, we have demonstrated for the first time how protein-based artificial 327 
viruses, namely functional nanoparticles formed by self-assembling protein shells 328 
shielding a core DNA, can be generated by the fully de novo design of building blocks. 329 
This fact not only validates R9 and H6 as pleiotropic peptides in vehicles for non-viral 330 
gene therapy, but it also reveals an unexpected architectonic potential of these tags in 331 
the generation of tuneable protein shells, whose properties can be further polished by 332 
conventional protein engineering. These versatile agents are promising alternatives to 333 
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natural protein constructs, including viruses, VLPs, vaults and BMCs, which because of 334 
several limitations including rigid architecture but also biosafety concerns, are less 335 
suitable for engineering and adaptation to nanomedical purposes.  336 
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 465 
Figure 1. Molecular architecture of R9-GFP-H6-DNA polyplexes. A) Size distribution of 466 
R9-GFP-H6 in absence of DNA, at different pH values. Some of the data shown here 467 
have been published previously [15]. B) Size distribution of R9-GFP-H6-DNA 468 
polyplexes formed at different pH values. DNA alone is shown as a control. C) DNA 469 
mobility assay (using pTurbo FP635 [11] as reporter DNA) of R9-GFP-H6-DNA 470 
polyplexes formed at pH 5.8. GFP-H6 is shown as a control, non-binding protein.  471 
 472 
 473 
Figure 2. Microscopic analysis of R9-GFP-H6-DNA polyplexes. A) Left. Spherical-474 
shaped green fluorescent signal in HeLa cells exposed for 24 hours to R9-GFP-H6-475 
DNA polyplexes. Right. Spherical-shaped blue labels for the same field, corresponding 476 
to the embedded DNA. B) Left. Rod-shaped green fluorescent signal in HeLa cells 477 
exposed for 24 hours to R9-GFP-H6-DNA polyplexes. Right. The same field, showing 478 
blue fluorescence corresponding to the embedded DNA. C) Isosurface representation 479 
of polyplexes within a 3D volumetric x-y-z data field, showing the inner localization of 480 
the cargo DNA. Magnification increases in the bottom image. D) Superimposition of 481 
TMV nanodisks and a R9-GFP-H6 molecular model of a stable, planar oligomer [43]. 482 
Arginines in the TMV coat protein are located in a radial distribution surrounding the 483 
inner hole (shadowed in yellow, inset), in parallel to those of the R9 tail in R9-GFP-H6 484 
monomers. E) TEM analysis of cell-free R9-GFP-H6 nanoparticles. F) R9-GFP-H6 485 
alone internalized into cultured HeLa cells (upon exposure for 24 h) showing the 486 
absence of any associated DNA.  487 
  488 
Figure 3. Functional and structural profiling of DNA-loaded nanoparticles. A) 489 
Remaining plasmid DNA after treatment with DNAse I, resulting from protection 490 
mediated by protein shells at alternative retardation units. Different modular proteins 491 
were tested as indicated. At the right, the digestion of protein-free DNA is shown under 492 
22 
 
the same conditions. T indicates time of digestion in min. B) Determination of the z-493 
potential of R9-GFP-H6 nanoparticles, with and without DNA. 494 
 495 
Figure 4. Potential intermolecular contacts in R9-GFP-H6 protein oligomers and in R9-496 
GFP-H6-DNA polyplexes. A) Protein-protein model configurations were obtained by 497 
docking simulations using HADDOCK at neutral pH, assuming a pentameric 498 
composition that is in agreement with experimental size of protein-only particles. The 499 
first model (left) was obtained using R9 residues as active and H6 residues as passive 500 
[43] and it was used for the superimposition depicted in Figure 2 e. The remaining 501 
three models derived from using R9 residues as active and no passive ones. No 502 
significant differences in packing were obtained when performing the docking runs at 503 
pH 5.8, i.e. with doubly-protonated His (not shown). B) Superposition of the 50 504 
solutions with highest score from a (1:1) DNA-protein docking simulation. The structural 505 
fitting is based on the DNA molecule, which is shown in red. 506 
 507 
 508 
 509 
